Phosphotransferase (Hydroxyl-accepting Kinase) (OH-acceptor)

The term 'OH-acceptors' is a functional and mechanistic classification rather than a specific biological target. In the context of drug discovery and pharmacology, it primarily refers to kinases (phosphotransferases) that catalyze the transfer of phosphate groups to the hydroxyl groups of various substrates, including lipids like phosphatidylinositol or proteins with serine, threonine, or tyrosine residues [1, 4]. This classification is frequently used by chemical suppliers to categorize enzymes like Phosphatidylinositol 3-kinase (PI3K) and Sphingosine Kinase (SphK), which play central roles in the PI3K/AKT/mTOR and sphingolipid signaling pathways [1, 4]. Dysregulation of these 'OH-acceptor' kinases is a hallmark of numerous pathologies, particularly malignancies where hyperactivation drives uncontrolled cell growth and survival. Consequently, they are high-priority therapeutic targets, with several approved drugs designed to inhibit their activity [1, 6]. Beyond enzymology, the term is also used in medicinal chemistry and structural biology to describe hydrogen bond acceptors (typically oxygen atoms) in docking studies and glycosylation reactions, where a specific hydroxyl group on a carbohydrate acts as a nucleophile [7, 12, 14]. Identifying a target simply as an 'OH-acceptor' is considered non-canonical and imprecise for clinical purposes, as it encompasses a vast family of enzymes with diverse physiological roles.

Other names

Hydroxyl group acceptorKinase (OH-acceptor)H-bond acceptorNucleophilic hydroxyl groupAlcohol phosphotransferase

Kinases classified as OH-acceptors act by facilitating the transfer of a phosphate group from ATP to a nucleophilic hydroxyl (-OH) group on a substrate, such as a protein (Serine/Threonine/Tyrosine), a lipid, or a carbohydrate. Therapeutic agents targeting these molecules typically act as ATP-competitive inhibitors or allosteric modulators that block this catalytic phosphorylation process, thereby halting downstream signaling cascades.